Medication commonly used to treat blood pressure could actually help to cure addiction, according to a new study. According to the study, published in the journal Molecular Psychiatry, the treatment could help ward off relapses by erasing memories in the subconscious that trigger addiction. The experimental drug has already been approved by the U.S. Food and Drug Administration (FDA).
The FDA has given their approval to a new drug made to combat LDL or "bad" cholesterol. The drug, Sanofi's drug Praluent, is an inhibitor that blocks the PCSK9, which is an enzyme that slows the body's ability to manage cholesterol. "If we could change our population mean LDL cholesterol to ranges that we haven't been able to achieve with any previous form of treatment . . ."
A committee of medical advisors is considering whether or not to recommend that the Food and Drug Administration approve "the little pink pill," known by its generic name, flibanserin, and commonly called the female Viagra, the first drug that aims to boost a woman's libido. The FDA has twice before rejected the drug after previous advisory panels concluded there were questions about its safety.